Publications All2015 Developments in oncological positron emission tomography/computed tomography assessment Implementing amplicon-based next generation sequencing in the diagnosis of small cell lung carcinoma metastases Afatinib in Non-Small Cell Lung Cancer Harboring Uncommon EGFR Mutations Pretreated With Reversible EGFR Inhibitors. Targeted Therapy for Patients with BRAF-Mutant Lung Cancer: Results from the European EURAF Cohort. NOTCH, ASCL1, p53 and RB alterations define an alternative pathway driving neuroendocrine and small cell lung carcinomas. A Modeling and Simulation Framework for Adverse Events in Erlotinib-Treated Non-Small-Cell Lung Cancer Patients. Impact of PET/CT image reconstruction methods and liver uptake normalization strategies on quantitative image analysis. Comprehensive genomic profiles of small cell lung cancer. Implementation of Amplicon Parallel Sequencing Leads to Improvement of Diagnosis and Therapy of Lung Cancer Patients. A Synergistic Interaction between Chk1- and MK2 Inhibitors in KRAS-Mutant Cancer. Spatial Tumor Heterogeneity in Lung Cancer with Acquired Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitor Resistance: Targeting High-Level MET-Amplification and EGFR T790M Mutation Occurring at Different Sites in the Same Patient. ROS1 rearrangements in lung adenocarcinoma: prognostic impact, therapeutic options and genetic variability. Crizotinib Therapy for Advanced Lung Adenocarcinoma and a ROS1 Rearrangement: Results From the EUROS1 Cohort. Activity and safety of nivolumab, an anti-PD-1 immune checkpoint inhibitor, for patients with advanced, refractory squamous non-small-cell lung cancer (CheckMate 063): a phase 2, single-arm trial. Management of crizotinib therapy for ALK-rearranged non-small cell lung carcinoma: An expert consensus. Modeling tumor dynamics and overall survival in advanced non-small-cell lung cancer treated with erlotinib PD-L1 expression in small cell neuroendocrine carcinomas. Identification of novel fusion genes in lung cancer using breakpoint assembly of transcriptome sequencing data.
